-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation